Journal of Alzheimer's Disease

GLP-1 receptor agonism in Alzheimer's disease after EVOKE: From single hypothesis to stratified program

By Anderson Matheus Pereira da Silva, Diogo Haddad Santos

CommentaryInterventions

The paper

Anderson Matheus Pereira da Silva, Diogo Haddad Santos

Cognitive and Neurodegenerative Disorders Research Group

Journal of Alzheimer's Disease, 10 Sep 2026

doi.org/10.1177/13872877261485580 PubMed 42720565

Alzheimer's & Dementia7 Oct 2026
Brain receptor gene activity linked to lower Alzheimer’s risk
Neurology Genetics4 Oct 2026
GLP-1 receptor agonists link to lower stroke and Alzheimer risk
Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Drug Design, Development and Therapy5 Oct 2026
GLP-1 agonists linked to lower dementia risk after COVID-19